Avalo Therapeutics Inc (AVTX) — Free Cash Flow Generation Index
Avalo Therapeutics Inc (AVTX) has a Free Cash Flow Generation Index of 0.99x as of September 2022. Free cash flow of $5.69 Million represents 1% of operating cash flow ($5.73 Million). See AVTX working capital ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Avalo Therapeutics Inc Free Cash Flow Generation Index (2017–2017)
Historical FCF Generation Index trend for Avalo Therapeutics Inc across 1 annual periods. Explore AVTX debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Avalo Therapeutics Inc (2017–2017)
Year-by-year Free Cash Flow Generation Index for Avalo Therapeutics Inc. For the full company profile including market capitalisation, see market cap of Avalo Therapeutics Inc.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2017 | 1.00x | $12.50 Million | $12.52 Million | $23.32K | — |